Europe PMCopen access
Microbiome-based therapeutics for <i>Clostridioides difficile</i> infection: additive, subtractive, and modulatory strategies in modern clinical practice
Fecal Microbiota Transplantation, Clostridioides Difficile, Microbiome Therapeutics, Anti-toxin Therapy, Live Biotherapeutic Products, Defined Microbial Consortia
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 676277
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.